IN2014MN00023A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN00023A IN2014MN00023A IN23MUN2014A IN2014MN00023A IN 2014MN00023 A IN2014MN00023 A IN 2014MN00023A IN 23MUN2014 A IN23MUN2014 A IN 23MUN2014A IN 2014MN00023 A IN2014MN00023 A IN 2014MN00023A
- Authority
- IN
- India
- Prior art keywords
- dazol
- facture
- manu
- propan
- trifluoro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161502656P | 2011-06-29 | 2011-06-29 | |
| PCT/GB2012/051503 WO2013001294A1 (en) | 2011-06-29 | 2012-06-27 | Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN00023A true IN2014MN00023A (es) | 2015-06-12 |
Family
ID=46420454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN23MUN2014 IN2014MN00023A (es) | 2011-06-29 | 2012-06-27 |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP2726464A1 (es) |
| JP (1) | JP2014527955A (es) |
| KR (1) | KR20140036230A (es) |
| CN (1) | CN103814015A (es) |
| AR (1) | AR086818A1 (es) |
| AU (1) | AU2012277514A1 (es) |
| BR (1) | BR112013031759A2 (es) |
| CA (1) | CA2839398A1 (es) |
| IN (1) | IN2014MN00023A (es) |
| MX (1) | MX2013014566A (es) |
| RU (1) | RU2013153466A (es) |
| SG (1) | SG195309A1 (es) |
| TW (1) | TW201305115A (es) |
| UY (1) | UY34170A (es) |
| WO (1) | WO2013001294A1 (es) |
| ZA (1) | ZA201309480B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017161518A1 (en) | 2016-03-23 | 2017-09-28 | Astrazeneca Ab | New physical form |
| CN108314670B (zh) * | 2018-02-06 | 2020-04-07 | 江苏八巨药业有限公司 | 一种(s)-2-氯-1-(6-氟-1-苯并二氢吡喃-2-基)-乙醇的制备方法 |
| WO2022114105A1 (ja) * | 2020-11-27 | 2022-06-02 | ミライラボバイオサイエンス株式会社 | 高純度βニコチンアミドモノヌクレオチド（ＮＭＮ）及びその製造方法 |
| KR102571432B1 (ko) * | 2023-02-08 | 2023-08-29 | 주식회사 에스씨엘테라퓨틱스 | 인다졸릴에스테르 및 아미드 유도체를 포함하는 암 치료용 조성물 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302777D0 (sv) | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| SE9101090D0 (sv) | 1991-04-11 | 1991-04-11 | Astra Ab | Process for conditioning of water-soluble substances |
| GB0315509D0 (en) | 2003-07-02 | 2003-08-06 | Meridica Ltd | Dispensing device |
| JO2754B1 (en) | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
| WO2008079073A1 (en) | 2006-12-22 | 2008-07-03 | Astrazeneca Ab | Indazolyl sulphonamide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| US20140083422A1 (en) | 2010-07-21 | 2014-03-27 | Astrazeneca Ab | Inhaler |
| WO2012010878A1 (en) | 2010-07-21 | 2012-01-26 | Astrazeneca Ab | Inhaler |
-
2012
- 2012-06-27 CA CA2839398A patent/CA2839398A1/en not_active Abandoned
- 2012-06-27 JP JP2014517935A patent/JP2014527955A/ja active Pending
- 2012-06-27 AU AU2012277514A patent/AU2012277514A1/en not_active Abandoned
- 2012-06-27 SG SG2013089966A patent/SG195309A1/en unknown
- 2012-06-27 BR BR112013031759A patent/BR112013031759A2/pt not_active IP Right Cessation
- 2012-06-27 KR KR1020137033086A patent/KR20140036230A/ko not_active Application Discontinuation
- 2012-06-27 RU RU2013153466/04A patent/RU2013153466A/ru not_active Application Discontinuation
- 2012-06-27 WO PCT/GB2012/051503 patent/WO2013001294A1/en active Application Filing
- 2012-06-27 CN CN201280039142.8A patent/CN103814015A/zh active Pending
- 2012-06-27 EP EP12731150.4A patent/EP2726464A1/en not_active Withdrawn
- 2012-06-27 MX MX2013014566A patent/MX2013014566A/es not_active Application Discontinuation
- 2012-06-27 IN IN23MUN2014 patent/IN2014MN00023A/en unknown
- 2012-06-28 TW TW101123228A patent/TW201305115A/zh unknown
- 2012-06-28 UY UY0001034170A patent/UY34170A/es not_active Application Discontinuation
- 2012-06-29 AR ARP120102359A patent/AR086818A1/es unknown
-
2013
- 2013-12-13 ZA ZA2013/09480A patent/ZA201309480B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR086818A1 (es) | 2014-01-22 |
| BR112013031759A2 (pt) | 2016-12-13 |
| KR20140036230A (ko) | 2014-03-25 |
| UY34170A (es) | 2013-01-31 |
| EP2726464A1 (en) | 2014-05-07 |
| TW201305115A (zh) | 2013-02-01 |
| RU2013153466A (ru) | 2015-08-10 |
| CN103814015A (zh) | 2014-05-21 |
| ZA201309480B (en) | 2015-10-28 |
| WO2013001294A1 (en) | 2013-01-03 |
| JP2014527955A (ja) | 2014-10-23 |
| SG195309A1 (en) | 2013-12-30 |
| MX2013014566A (es) | 2014-09-25 |
| AU2012277514A1 (en) | 2014-01-09 |
| CA2839398A1 (en) | 2013-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY164274A (en) | Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
| IL248246B (en) | (5r,2s)-6-(benzyloxy/allyloxy)-7-oxo-6,1-diazabicyclo[1.2.3]octane-2-carboxylates, process for their preparation and use of (5r,2s)-tert-butyl-6 -(benzyloxy)-7-oxo-6,1-diazabicyclo[1.2.3]octane-2-carboxylate for the preparation of anti-infective drugs | |
| PH12014502524A1 (en) | Carboxylic acid compounds | |
| MX2013014843A (es) | Oxazepinas como moduladores del canal de iones. | |
| WO2010139979A3 (en) | Processes for preparing crystalline forms of dasatinib | |
| MX336810B (es) | Benzoxazepinonas fusionadas como moduladoras de canales ionicos. | |
| MX2013014007A (es) | [1,3] oxazinas. | |
| MX2013007558A (es) | 1,4-oxazinas como inhibidores de los genes enzima de segmentacion de la proteina precursora del sitio 1 y/o 2 (bace1 y/o bace2). | |
| MX2014007897A (es) | Nuevos derivados de azetidina, composiciones farmaceuticas y sus usos. | |
| MD20120050A2 (en) | New agomelatine cocrystals, process for their preparation and pharmaceutical compositions containing them | |
| MX2014000635A (es) | Derivados de piridin-2(1h)-ona como inhibidores de jak. | |
| EA201391026A1 (ru) | Кристаллическое производное оксазина и его применение в качестве ингибитора bace | |
| IN2014MN00023A (es) | ||
| HK1193087A1 (en) | New crystal form vii of agomelatine, preparation method and use thereof and pharmaceutical composition containing same vii | |
| IL229005A (en) | Pyrazolidine-3-derivatives, their process, their preparations and their use in the preparation of schizophrenia and cognitive diseases | |
| IN2012DN01292A (es) | ||
| TN2013000377A1 (en) | Thieno [2, 3-d] pyrimidine derivatives and their use to treat arrhythmia | |
| WO2012159704A8 (en) | Stable crystal modifications of dotap chloride | |
| NZ601452A (en) | Use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd) | |
| NZ700507A (en) | Pyrimidine derivatives for the treatment of bacterial diseases | |
| IN2014DN10683A (es) | ||
| TN2013000146A1 (en) | Salt(s) of 7-cyclopentyl-2 -(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof | |
| HU0900281D0 (en) | Kynurenc acid derivatives, process for their preparation, pharmaceutical compositions containing them and their use for the treatment of headache | |
| MX2015006807A (es) | Metodo de preparacion de formas cristalinas de la 4-(ciclopropilmetoxi)-n-(3,5-dicloro-1-oxidopiridin-4-il)-5-metox ipiridin-2-carboxamida y sus formas cristalinas. | |
| EP2732822A4 (en) | THERAPEUTIC AGENT AGAINST BONE BREAK, BONE GROWTH AMPLIFIER OR THERAPEUTIC OR PROPHYLACTIC AGGREGATE AGAINST BONE DISORDERS WITH CARBON DIOXIDE AS ACTIVE AGENT |